Selective serotonin reuptake inhibitor treatment retunes emotional valence in primate ventral striatum
Selective serotonin reuptake inhibitor treatment retunes emotional valence in primate ventral striatum
复制标题
选择性血清素再摄取抑制剂治疗可重新调整灵长类腹侧纹状体的情绪效价
作者:
B. Pasquereau;G. Drui;Y. Saga;Augustin Richard;Mathilde Millot;E. Météreau;V. Sgambato;P. Tobler;L. Tremblay
Selective serotonin reuptake inhibitors (SSRIs) are widely used to treat psychiatric disorders with affective biases such as depression and anxiety. How SSRIs exert a beneficial action on emotions associated with life events is still unknown. Here we ask whether and how the effectiveness of the SSRI fluoxetine is underpinned by neural mechanisms in the ventral striatum. To address these issues, we studied the spiking activity of neurons in the ventral striatum of monkeys during an approach-avoidance task in which the valence assigned to sensory stimuli was manipulated. Neural responses to positive and negative events were measured before and during a 4-week treatment with fluoxetine. We conducted PET scans to confirm that fluoxetine binds within the ventral striatum at a therapeutic dose. In our monkeys, fluoxetine facilitated approach of rewards and avoidance of punishments. These beneficial effects were associated with changes in tonic and phasic activities of striatal neurons. Fluoxetine increased the spontaneous firing rate of striatal neurons and amplified the number of cells responding to rewards versus punishments, reflecting a drug-induced positive shift in the processing of emotionally valenced information. These findings reveal how SSRI treatment affects ventral striatum neurons encoding positive and negative valence and striatal signaling of emotional information. In addition to a key role in appetitive processing, our results shed light on the involvement of the ventral striatum in aversive processing. Together, the ventral striatum appears to play a central role in the action of SSRIs on emotion processing biases commonly observed in psychiatric disorders.
DOI:
10.1176/appi.ajp.2012.12010014
发表时间:
2013-02
期刊:
The American journal of psychiatry
影响因子:
--
作者:
Heller AS;Johnstone T;Light SN;Peterson MJ;Kolden GG;Kalin NH;Davidson RJ
通讯作者:
Davidson RJ
DOI:
10.1016/s2215-0366(17)30015-9
发表时间:
2017-05
期刊:
The lancet. Psychiatry
影响因子:
--
作者:
Harmer CJ;Duman RS;Cowen PJ
通讯作者:
Cowen PJ